13,850
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

Challenges for biosimilars: focus on rheumatoid arthritis

ORCID Icon, , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 121-153 | Received 24 Dec 2019, Accepted 30 Aug 2020, Published online: 11 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hanxiao Liu, Hui Lv, Xuehui Duan, Yan Du, Yixuan Tang & Wei Xu. (2023) Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management. International Journal of Nanomedicine 18, pages 6915-6940.
Read now

Articles from other publishers (9)

Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, Dinand Rienk Hoven, Linda Berendina Benoist, Wytske Johanna Fokkens & Sietze Reitsma. (2023) Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy.
Crossref
Radha Rani, Neha Raina, Ajay Sharma, Pramod Kumar, Hardeep Singh Tulli & Madhu Gupta. (2023) Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Huarui Shao, Yi Tao & Chengyong Tang. (2023) Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model. Frontiers in Pharmacology 14.
Crossref
Yeong Mi Lee, Sanggi Lee & Won Jong Kim. (2023) Nitric oxide scavengers based on o -phenylenediamine for the treatment of rheumatoid arthritis . Biomaterials Science 11:7, pages 2395-2404.
Crossref
Abdul Malik, Ajmal Khan, Qaisar Mahmood, Muhammad Mudassir Ali Nawaz Marth, Muhammad Riaz, Tahira Tabassum, Ghulam Rasool, Muhammad Fayyaz ur Rehman, Aima Iram Batool, Fariha Kanwal & Rujie Cai. (2022) In Vivo and In Silico Assessment of the Cardioprotective Effect of Thymus linearis Extract against Ischemic Myocardial Injury . ACS Omega 7:48, pages 43635-43646.
Crossref
Zhiming Jiao, Ganyi Wang, Zhanchun Feng, Ziqi Yan, Jinwen Zhang, Gang Li, Qianyu Wang & Da Feng. (2022) Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database. Frontiers in Pharmacology 12.
Crossref
Muhammad Sarfraz, Chenxi Wang, Nargis Sultana, Humna Ellahi, Muhammad Fayyaz ur Rehman, Muhammad Jameel, Shahzaib Akhter, Fariha Kanwal, Muhammad Ilyas Tariq & Song Xue. (2021) 2,3-Dihydroquinazolin-4(1H)-one as a New Class of Anti-Leishmanial Agents: A Combined Experimental and Computational Study. Crystals 12:1, pages 44.
Crossref
Hirra Hussain, Tulshi Patel, Angelica M. S. Ozanne, Davide Vito, Mark Ellis, Matthew Hinchliffe, David P. Humphreys, Paul E. Stephens, Bernie Sweeney, James White, Alan J. Dickson & Christopher M. Smales. (2021) A comparative analysis of recombinant Fab and full‐length antibody production in Chinese hamster ovary cells. Biotechnology and Bioengineering 118:12, pages 4815-4828.
Crossref
S. Fernandez-Poza, A. Padros, R. Thompson, Lucy Butler, Meez Islam, J.A. Mosely, James H. Scrivens, Muhammad F Rehman & Muhammad Safwan Akram. (2021) Tailor-made recombinant prokaryotic lectins for characterisation of glycoproteins. Analytica Chimica Acta 1155, pages 338352.
Crossref